Outstanding Results on Research in Synchrotron Radiation rewarded

At the “First Joint BER II and BESSY II Users´ Meeting” on November 12th / 13th the “Freundeskreis Helmholtz-Zentrum Berlin e. V.” bestowed the “Ernst-Eckhard-Koch-Prize" and the „Innovation-Award on Synchrotron Radiation“ for 2009.

Sahe

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • 13 trainees start their careers at HZB
    News
    05.09.2024
    13 trainees start their careers at HZB
    A new phase of life began for 13 young people on 2 September: HZB welcomed five new trainees, six students on dual study programmes and two participants in a Voluntary Year of Science. They all are starting their careers with great anticipation.

  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.